Alzheimer Disease Clinical Trials in Paris
14 recruitingParis, France
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled140 locationsNCT07011745
Recruiting
Phase 3
Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
Alzheimer Disease, Early Onset
Assistance Publique - Hôpitaux de Paris240 enrolled1 locationNCT04661280
Recruiting
Not Applicable
The Ketogenic Diet for Alzheimer's Disease
Alzheimer Disease, Early Onset
Assistance Publique - Hôpitaux de Paris70 enrolled1 locationNCT04701957
Recruiting
Not Applicable
OCT-Angiography and Adaptive Optics in Patients With Memory Impairment
Alzheimer DiseaseLewy Body DiseaseParkinsons Disease with Dementia+1 more
Fondation Ophtalmologique Adolphe de Rothschild450 enrolled1 locationNCT04389437
Recruiting
Phase 1
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Alzheimer DiseaseMild Cognitive Impairment
Novartis Pharmaceuticals36 enrolled10 locationsNCT05469360
Recruiting
Not Applicable
Lack of Decision-making in Patients With Alzheimer's Disease : Functions Involved and the Daily Consequences
Alzheimer Disease
Centre Hospitalier Universitaire de Saint Etienne180 enrolled4 locationsNCT03991624
Recruiting
Not Applicable
Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG
Alzheimer DiseaseAging
Assistance Publique - Hôpitaux de Paris90 enrolled1 locationNCT06501495
Recruiting
Not Applicable
Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
Alzheimer Disease
REGEnLIFE SAS108 enrolled6 locationsNCT05926011
Recruiting
Not Applicable
Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD
Alzheimer Disease
Assistance Publique - Hôpitaux de Paris244 enrolled1 locationNCT06582199
Recruiting
ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions
Alzheimer DiseaseFrontotemporal Dementia, Behavioral Variant
Institut National de la Santé Et de la Recherche Médicale, France120 enrolled1 locationNCT04865172
Recruiting
Not Applicable
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
Alzheimer Disease, Early OnsetPosterior Cortical Atrophy
Institut National de la Santé Et de la Recherche Médicale, France45 enrolled2 locationsNCT04150198
Recruiting
Not Applicable
Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
Alzheimer Disease
Centre Hospitalier St Anne90 enrolled3 locationsNCT05911178
Recruiting
Phase 2
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
Alzheimer Disease
Centre Hospitalier St Anne45 enrolled1 locationNCT05468073